GSK2231395A
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK2231395A, covering 2017-10-31 to 2017-10-31. Get the full timeline:
Most recent: Clinical Trial Update: Study to Assess the Safety of a New GSK Biologicals' GSK2231395A Candidate Vaccine [Phase 1]